Austco HealthcareASX:AHC +11.36%70 EBITDA Margin % is 17.34% as of Dec. 2025, which is 90% above its 10-year median of 9.15. GuruFocus rates ASX:AHC with a GF Score™ of 70/100 and a GF Value™ of A$0.33 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Austco Healthcare ranks better than 65.69% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Austco Healthcare's EBITDA for the
six
months ended in Dec. 2025 was A$8.37 Mil. Austco Healthcare's Revenue for the
six
months ended in Dec. 2025 was A$48.24 Mil. Therefore, Austco Healthcare's EBITDA margin for the quarter that ended in Dec. 2025 was 17.34%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Austco Healthcare EBITDA Margin % Related Terms
Austco Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Austco Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHC vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Austco Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a EBITDA Margin % of 17.34% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Austco Healthcare and its competitors. This is 90% above median its historical median of 9.15. According to the industry distribution chart, Austco Healthcare ranks #280 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 34.3%.
Is Austco Healthcare's EBITDA Margin % too high?
Austco Healthcare's current EBITDA Margin % of 17.34% is 90% above median its 10-year median of 9.15. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Austco Healthcare's value of 17.34% is 132% above this industry median. Based on the distribution chart, Austco Healthcare ranks #280 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Austco Healthcare has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #280 out of 816 companies for EBITDA Margin %. This puts Austco Healthcare in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Austco Healthcare's value of 17.34% is 132% above this benchmark. While the company's 10-year median is 9.15 vs. the industry median of 7.48, Austco Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current EBITDA Margin % of 17.34% is 132% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Austco Healthcare and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current EBITDA Margin % is 17.34%, which is 90% above median its own 10-year median of 9.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.33, compared to a current price of A$0.25 — trading 25.8% below its estimated fair value. The current EBITDA Margin % is 17.34%, which is 90% above median its 10-year median of 9.15 and 132% above the Medical Devices & Instruments industry median of 7.48. Austco Healthcare's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current EBITDA Margin % is 17.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.25 is trading 25.8% below its estimated GF Value™ of A$0.33.
GuruFocus considers Austco Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:AHC:
EBITDA Margin %: 17.34% (90% above median its 10-year median of 9.15)
GF Value™: A$0.33 vs. price of A$0.25 (25.8% below fair value)
Industry Position: 132% above the Medical Devices & Instruments median (#280 of 816)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
70GF Score
Get the complete analysis for ASX:AHC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
